RANI Rani Therapeutics Holdings, Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
11:49
May 16
May 16
Long $RANI (Rani Therapeutics) — clinical-stage pharma/medtech developing oral form for peptides/proteins, partnership with Chugai, cash runway until Q4 2027, MC $200M; potential buyout target. Speaker took a tiny speculative position.
MED
About RANI Analyst Coverage
Buzzberg tracks RANI (Rani Therapeutics Holdings, Inc.) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.